Journal: Regenerative Therapy
Article Title: Beyond conventional therapies: MSCs in the battle against nerve injury
doi: 10.1016/j.reth.2024.12.017
Figure Lengend Snippet: MSC-based clinical trials for nerve injury and spinal cord injury (SCI).
Article Snippet: An Indian company known as Stempeutics conducted a phase 4 clinical trial in September 2021, and the results indicated that Stempeucel's allogeneic BM-MSCs product was safe, effective, and had positive, long-lasting effects that not only reduced pain but aided in ulcer healing for severe limb ischemia triggered by Buerger's disease.
Techniques: Clinical Proteomics, Transplantation Assay, Derivative Assay, Diffusion-based Assay, Imaging, Membrane, Cell Culture, Injection